Rhythm Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 7.22 M | $378.09 M | -1.31% | 11.79% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 6.89 M | $360.93 M | 100.00% | 11.25% |
BAKER BROS. ADVISORS LP | 11/14/2024 | 6.40 M | $335.21 M | 0.00% | 10.45% |
RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 6.08 M | $318.76 M | 0.00% | 9.94% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 3.88 M | $203.26 M | -26.64% | 6.34% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 3.56 M | $186.52 M | 3.30% | 5.82% |
VANGUARD GROUP INC | 11/13/2024 | 3.45 M | $180.64 M | 2.60% | 5.63% |
NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 2.91 M | $152.45 M | 0.00% | 4.75% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 2.42 M | $126.62 M | 1.93% | 3.95% |
STATE STREET CORP | 11/14/2024 | 1.99 M | $104.42 M | -0.53% | 3.26% |
POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 1.50 M | $78.59 M | 0.00% | 2.45% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.30 M | $68.08 M | 9.91% | 2.12% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.26 M | $65.82 M | 0.28% | 2.05% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.23 M | $64.34 M | -4.09% | 2.01% |
ALKEON CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.17 M | $61.18 M | 16.77% | 1.91% |
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 11/13/2024 | 1.11 M | $58.21 M | 14.87% | 1.81% |
CHECKPOINT CAPITAL L.P. | 11/14/2024 | 663,381 | $34.75 M | -28.06% | 1.08% |
COMMODORE CAPITAL LP | 11/14/2024 | 650,000 | $34.05 M | -46.94% | 1.06% |
LOOMIS SAYLES & CO L P | 11/13/2024 | 636,628 | $33.35 M | 100.00% | 1.04% |
HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 614,598 | $32.20 M | 100.00% | 1.00% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 598,122 | $31.34 M | 0.75% | 0.98% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 550,530 | $28.84 M | 4.68% | 0.90% |
OPALEYE MANAGEMENT INC. | 11/14/2024 | 500,000 | $26.20 M | -2.91% | 0.82% |
MORGAN STANLEY | 11/14/2024 | 464,604 | $24.34 M | -2.32% | 0.76% |
ORBIMED ADVISORS LLC | 11/14/2024 | 435,900 | $22.84 M | -38.16% | 0.71% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 433,866 | $22.73 M | 1.38% | 0.71% |
MARSHALL WACE, LLP | 11/14/2024 | 406,615 | $21.30 M | 280.69% | 0.66% |
CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 400,000 | $20.96 M | -15.79% | 0.65% |
CANDRIAM S.C.A. | 11/13/2024 | 395,377 | $20.71 M | 45.68% | 0.65% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 353,323 | $18.51 M | -23.55% | 0.58% |
NATIONAL BANK OF CANADA /FI/ | 11/15/2024 | 341,507 | $17.89 M | -15.52% | 0.56% |
PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 329,339 | $17.25 M | -58.92% | 0.54% |
SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 276,678 | $14.50 B | 100.00% | 0.45% |
INVESCO LTD. | 11/12/2024 | 264,417 | $13.85 M | -4.44% | 0.43% |
FRANKLIN RESOURCES INC | 11/27/2024 | 259,416 | $13.03 M | 11.49% | 0.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 255,578 | $13.39 M | 38.40% | 0.42% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 232,600 | $12.19 M | 148.77% | 0.38% |
CAPTION MANAGEMENT, LLC | 11/14/2024 | 190,800 | $10.00 M | 281.60% | 0.31% |
JANE STREET GROUP, LLC | 11/15/2024 | 186,300 | $9.76 M | 100.00% | 0.30% |
SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 172,647 | $9.04 M | 0.00% | 0.28% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 148,926 | $7.80 M | -22.38% | 0.24% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 147,875 | $7.75 M | -0.83% | 0.24% |
WOODLINE PARTNERS LP | 11/14/2024 | 143,823 | $7.53 M | 225.05% | 0.23% |
GREAT LAKES ADVISORS, LLC | 11/04/2024 | 136,950 | $7.17 M | 100.00% | 0.22% |
ABRDN PLC | 10/25/2024 | 112,804 | $5.91 M | 0.00% | 0.18% |
JANE STREET GROUP, LLC | 11/15/2024 | 109,186 | $5.72 M | -25.47% | 0.18% |
BARCLAYS PLC | 11/19/2024 | 106,397 | $5.57 M | 98.39% | 0.17% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 106,250 | $5.57 M | 15.44% | 0.17% |
VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 102,832 | $5.39 M | 171.96% | 0.17% |
CITADEL ADVISORS LLC | 11/14/2024 | 102,778 | $5.38 M | 100.00% | 0.17% |
Rhythm Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 200 institutional investors and hedge funds held shares of Rhythm Pharmaceuticals, Inc.. The most heavily invested institutionals were:
PRIMECAP MANAGEMENT CO/CA/: 7.22 M
BlackRock Funding, Inc. /DE: 6.89 M
BAKER BROS. ADVISORS LP: 6.4 M
RA CAPITAL MANAGEMENT, L.P.: 6.08 M
GOLDMAN SACHS GROUP INC: 3.88 M
PERCEPTIVE ADVISORS LLC: 3.56 M
110.49% of Rhythm Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 72.08 M shares in the last 24 months. This purchase volume represents approximately $4.23 B in transactions.